Chester County News and Community Website
Galera Therapeutics, Inc. (Nasdaq: GRTX), headquartered in Malvern, PA, is a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced financial results for the third quarter ended September 30, 2021 and provided recent corporate updates.
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) this weekannounced results from the Phase 3 ROMAN trial of avasopasem manganese (avasopasem) for severe oral mucositis (SOM) in patients with locally …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced the recent appointment of Mark J. Bachleda, Pharm.D., M.B.A., as Chief Commercial Officer (CCO) and Jennifer Evans Stacey, Esq., as Chief …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that the Company will host a virtual Key Opinion Leader event on radiotherapy-induced severe oral mucositis (SOM) in patients with head …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced final results from its Phase 1/2 pilot trial of its dismutase mimetic, GC4419, versus placebo, in patients with unresectable or borderline …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that Mel Sorensen, M.D., President and Chief Executive Officer, will present at three upcoming virtual investor conferences in September.
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) recently announced financial results for the second quarter ended June 30, 2021, and highlighted recent corporate accomplishments.
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) recently announced the completion of enrollment in its pivotal Phase 3 ROMAN trial of avasopasem manganese (avasopasem) for the treatment of severe …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that Mel Sorensen, M.D., President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, …
Read More MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy …
Read More